Example: Heart Attack

Clinical Trials on Glabellar Crease

Total 10000 results

NCT00553410

Completed

Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer (SOLE)

Breast Cancer
NCT03367676

Unknown

12 weekS Adjuvant dOcetaxel Plus trastuzumaB in Patients With Small, Node-negative, HER2-positive Breast cancER (SOBER) (SOBER)

Breast Cancer
NCT00331630

Completed

Abraxane and Lapatinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer

Breast Cancer
NCT02067351

Completed

Mindfulness-Based Intervention in Breast Cancer Patients Undergoing Chemotherapy

Breast Cancer
NCT03721211

Withdrawn

Imaging With [11C]Martinostat in Breast Cancer

Breast Cancer
NCT04208074

Unknown

Exercise Study for Breast Cancer Survivors

Breast Cancer
NCT00968214

Completed

Study of Tumor and Blood Samples From Postmenopausal Women With Primary Breast Cancer Enrolled on Clinical Trial CAN-NCIC-MA27

Breast Cancer
NCT00278109

Completed

Partial Breast Irradiation With Chemotherapy

Breast Cancer
NCT02291913

Completed

Everolimus Combined With Anti-estrogen Therapy in Hormone-Receptor-Positive HER-2 Negative Advanced Breast Cancer

Breast Cancer
NCT01299038

Completed

Rosuvastatin to Lower Circulating Tissue Factor Bearing Microparticles in Metastatic Breast Cancer

Breast Cancer
NCT03295916

Unknown

Stereotactic Body Radiotherapy for Patients With Breast Cancer Oligometastasis (STOMP)

Breast Cancer
NCT01484080

Completed

Neoadjuvant Paclitaxel Versus BIBF 1120 Priming Followed by BIBF 1120 Plus Paclitaxel in Early HER-2 Negative Breast Cancer With Proteomic and Dynamic Imaging Correlates

Breast Cancer
NCT00910884

Unknown

Plant Extracted Natural Compounds Impact on Stage IV Breast Cancer Survival Time and Remission.

Breast Cancer
NCT02455453

Completed

Assessment of Functional Status of Estrogen Receptors in Breast Cancer by Positron Emission Tomography

Breast Cancer
NCT00896727

Completed

S9313A Protein Expression Analysis of Breast Cancer Tissue Microarrays From Clinical Trial SWOG-9313

Breast Cancer
NCT02673918

Completed

The Breast Cancer Online Rehabilitation Program (BRECOR)

Breast Cancer
NCT03402997

Completed

Tissue Resistivity in Breast Cancer Patients

Breast Cancer
NCT04190381

Unknown

A Study to Evaluate the Safety and Clinical Outcome of Using FR-Mask in Breast Cancer Patients With Radiation-irritated Skin After Radiotherapy

Breast Cancer
NCT00418210

Completed

Accelerated Partial Breast Irradiation for Early Breast Cancer

Breast Cancer
NCT04164251

Completed

Inpatient Screening Mammography for Non-adherent and High Risk Women

Breast Cancer
NCT04182568

Unknown

Nab-paclitaxel Compared With Docetaxel Followed by Anthracyclines and Cyclophosphamide in the Neoadjuvant Breast Cancer

Breast Cancer
NCT00213980

Completed

Bone Mineral Density Effects of Zoledronate in Postmenopausal Women With Breast Cancer

Breast Cancer
NCT00548184

Completed

Lapatinib and Trastuzumab With or Without Endocrine Therapy

Breast Cancer
NCT00451555

Completed

Enzastaurin Plus Fulvestrant vs. Placebo Plus Fulvestrant in Breast Cancer

Breast Cancer
NCT02839668

Completed

The Impact of Intravenous Anaesthesia on Angiogenesis in Patients With Breast Cancer (TIVA/TCI-BC) (TIVA/TCI-BC)

Breast Cancer
NCT02031042

Completed

Sentinel Node Biopsy Before and/or After Neoadjuvant Chemotherapy in Breast Cancer

Breast Cancer
NCT02754427

Completed

Pilot Study for a Prospective Surveillance Program for Rehabilitation Following Surgery for Breast Cancer

Breast Cancer
NCT02151747

Completed

Testing BRCA 1/2 Mutation Using Next Generation Sequencing (BRCANGS)

Breast Cancer | Breast Neoplasms
NCT02115204

Completed

4 x Epirubicin, Cyclophosphamide, Followed by 4 x Docetaxel Versus 6 x CMF / 6 x CEF

Breast Cancer
NCT04109326

Completed

Effect of a Program of Physical Activity and Nutritional Therapeutic Education in Breast Cancer Patients (APAD2)

Breast Cancer
NCT02995980

Completed

Study of Dual-energy (DE) Contrast-enhanced (CE) Digital Mammography

Breast Cancer
NCT00003302

Completed

MRI to Detect Breast Tumors in Women

Breast Cancer
NCT03777397

Completed

Awareness About Breast Cancer Screening (DEPSEIN_HCL)

Breast Cancer
NCT01926886

Completed

A Study of Subcutaneous At Home Administration of Trastuzumab (Herceptin) in Participants With Human Epidermal Growth Factor Receptor 2-positive (HER2+) Early Breast Cancer (eBC)

Breast Cancer
NCT02926547

Completed

New Approaches for the Identification and Characterization of Functional Markers of the Risk of Extension of Breast Cancer Without Lymph Node Involvement

Breast Cancer
NCT00191243

Completed

Docetaxel vs. Docetaxel-Gemcitabine in Breast Cancer

Breast Cancer
NCT01823107

Completed

Feasibility Study of Meso BioMatrix Device for Breast Reconstruction

Breast Cancer
NCT02402712

Completed

Phase IIIb Study to Evaluate the Safety and Tolerability of Herceptin SC With Perjeta and Docetaxel in Patients With HER2-positive Advanced Breast Cancer

Breast Cancer
NCT02506790

Unknown

Neoadjuvant Toremifene With Melatonin or Metformin in Locally Advanced Breast Cancer

Breast Cancer
NCT03572361

Unknown

Open Label Immunotherapy Trial for Breast Cancer (V3-MOMMO)

Breast Cancer
NCT00900367

Active, not recruiting

Nutrition-Related Biomarkers in Predicting Breast Cancer Risk in Women

Breast Cancer
NCT01901146

Completed

Efficacy and Safety Study of ABP 980 Compared With Trastuzumab in Women With HER2-positive Early Breast Cancer (Lilac)

Breast Cancer
NCT02101320

Completed

Hand-held Gamma Camera in the SNOLL Procedure (TRECAM)

Breast Cancer
NCT02603211

Completed

Tactile Breast Imaging Sensor for Tumor Malignancy Characterization

Breast Cancer
NCT04033965

Completed

Corellation of Mutations, TILs and Age in Breast Cancer

Breast Cancer
NCT03197805

Terminated

Assessment of the Impact of RNA Genomic Profile on Treatment Decision-making in HER2 Equivocal Breast Cancer Patients (EQUIVOK)

Breast Cancer
NCT02970682

Completed

SFX-01 in the Treatment and Evaluation of Metastatic Breast Cancer (STEM)

Breast Neoplasm
NCT00129376

Completed

Doxorubicin and Cyclophosphamide (AC) Followed by Weekly Docetaxel as Neoadjuvant Treatment of Breast Cancer Patients

Breast Cancer
NCT01562288

Completed

Studying Blood and DNA Samples From Patients With Breast Cancer Treated With Chemotherapy With or Without Trastuzumab

Breast Cancer
NCT02768415

Unknown

Study of Apatinib Combined With Oral Vinorelbine in Metastatic HER2 Negative Breast Cancer

Breast Cancer

Clinical Trials on Glabellar Crease

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations